Lyell Immunopharma, Inc. (LYEL)
19.94
-1.19
(-5.63%)
USD |
NASDAQ |
Mar 17, 16:00
19.94
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Profit Margin (Quarterly) : -2.35M% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Insmed, Inc. | -124.5% |
| Nektar Therapeutics | -165.4% |
| GT Biopharma, Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -86.00% |
| Return on Assets | -66.80% |
| Return on Invested Capital | -73.68% |
| Gross Profit Margin (Quarterly) | -39.85K% |
| Operating Margin (Quarterly) | -1.05M% |
| Return on Net Operating Assets | -430.8% |